We are live on ! Find out more
MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

68 hedge funds and large institutions have $350M invested in Mirati Therapeutics, Inc. Common Stock in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

15% less funds holding

Funds holding: 80 → 68 (-12)

30% less capital invested

Capital invested by funds: $499M → $350M (-$150M)

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.81%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
3
Increased
33
Reduced
18
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AH
Aviva Holdings
Bahamas
+$22.9M
2
BBA
Baker Bros. Advisors
New York
+$7.01M
3
QF
QVT Financial
New York
+$6.88M
4
PA
Perceptive Advisors
New York
+$6.1M
5
VAM
Visium Asset Management
New York
+$4.09M

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$28.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.22M
3
Morgan Stanley
Morgan Stanley
New York
-$2.09M
4
DCM
Driehaus Capital Management
Illinois
-$1.15M
5
SIM
Spark Investment Management
New York
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jennison Associates
26
Jennison Associates
New York
$1.41M +$12K +535 +0.8%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.31M +$113K +5,075 +9%
OAM
28
Oxford Asset Management
United Kingdom
$1.25M +$688K +30,769 +112%
SM
29
Sabby Management
Florida
$1.21M +$679K +30,373 +117%
RPAM
30
Rhenman & Partners Asset Management
Sweden
$1.07M – – –
Morgan Stanley
31
Morgan Stanley
New York
$1.03M -$2.09M -93,257 -66%
BIM
32
BlackRock Investment Management
Delaware
$869K +$19.3K +863 +2%
TCIM
33
TIAA CREF Investment Management
New York
$757K – – –
California State Teachers Retirement System (CalSTRS)
34
California State Teachers Retirement System (CalSTRS)
California
$520K +$67.2K +3,003 +14%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$497K -$47.9K -2,144 -8%
Swiss National Bank
36
Swiss National Bank
Switzerland
$434K +$110K +4,900 +30%
UBS Group
37
UBS Group
Switzerland
$429K -$426K -19,029 -49%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$412K +$85.6K +3,828 +25%
Charles Schwab
39
Charles Schwab
California
$387K – – –
TA
40
Teachers Advisors
New York
$352K – – –
CS
41
Credit Suisse
Switzerland
$312K -$231K -10,317 -41%
Citadel Advisors
42
Citadel Advisors
Florida
$274K -$405K -18,110 -59%
Citigroup
43
Citigroup
New York
$269K +$163K +7,288 +139%
TAM
44
Tocqueville Asset Management
New York
$256K -$224K -10,000 -46%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$255K – – –
AQR Capital Management
46
AQR Capital Management
Connecticut
$247K -$30.6K -1,367 -11%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$237K +$2.91K +130 +1%
MLICM
48
Metropolitan Life Insurance Company (MetLife)
New York
$222K – – –
BI
49
Boulegeris Investments
Georgia
$202K +$1.12K +50 +0.5%
VEA
50
Virtus ETF Advisers
New York
$168K +$175K +7,828 New
1
2
3 4

MRTX Hedge Fund Activity: Q1 2016 in Review

68 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Mirati Therapeutics, Inc. Common Stock (MRTX) for Q1 2016, worth a combined $350M — down 30% from $499M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of MRTX and 3 opened new positions — a net loss of 12 holders — while 18 trimmed existing stakes and 33 added.

The largest buyer was Aviva Holdings, adding an estimated $22.9M. The largest seller was Boxer Capital, cutting an estimated $28.3M.

  • 68 institutional investors held Mirati Therapeutics, Inc. Common Stock (MRTX) as of Q1 2016, down from 80 in Q4 2015.
  • Funds reported $350M of Mirati Therapeutics, Inc. Common Stock stock for Q1 2016, down 30% quarter-over-quarter.
  • 3 funds opened new Mirati Therapeutics, Inc. Common Stock positions in Q1 2016 and 15 closed out, a net change of -12 holders.
  • The largest Mirati Therapeutics, Inc. Common Stock buyer in Q1 2016 was Aviva Holdings, an estimated $22.9M added.
  • The largest Mirati Therapeutics, Inc. Common Stock seller in Q1 2016 was Boxer Capital, an estimated $28.3M sold.

Based on aggregated 13F filings for Q1 2016.